EXLS vs G: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: G is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. EXLS and G share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined EXLS and G exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

ExlService Holdings (Nasdaq: EXLS), which markets itself as EXL, is a global data and AI company that combines deep industry domain expertise with analytics, cloud, and machine learning to run complex operations and deliver insights for large enterprises. Its clients are concentrated in insurance, healthcare, banking and financial services, media, and retail, and the business splits into two reported lines: data and AI-led services (the growth engine, roughly 60% of revenue) and digital operations and solutions (the more mature outsourcing base). The company is headquartered in New York and employs about 65,000 people across six continents.

Full EXLS guide

Genpact Limited was spun out of GE's Indian back-office operations in 2005 and has spent two decades running processes that its clients would rather not run themselves: accounts payable, order-to-cash, procurement, claims handling, anti-money-laundering alert review, supply-chain planning and customer service. Revenue comes from long-duration contracts with roughly 800 clients concentrated in banking and capital markets, insurance, consumer goods, life sciences and high-tech manufacturing, delivered by a workforce of around 141,000 people spread across India, the Philippines, Eastern Europe and Latin America. Trailing twelve-month revenue is about ~$5.25 billion, and the business is structurally profitable, with gross margin near ~36.5% and a consistent record of converting earnings into free cash flow, dividends and buybacks.

Full G guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• EXLS drivers: Data and AI-led mix shift; Vertical domain depth.
• G drivers: Advanced Technology Solutions mix shift; Agent-shaped repackaging of existing service lines.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: AI is a double-edged sword: the same automation EXL sells could compress the value of its large digital-operations base, pressuring pricing and volumes over time, and that worry helps explain why the stock fell to about $25 at its 52-week low despite steady beats. For G, the central risk is that agentic AI compresses the price of the work Genpact performs faster than volumes or new offerings replace it, and analysts have flagged exactly this: ATS may not fully offset a slowing legacy base.

Pick EXLS if you believe its drivers more; G if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the EXLS and G guides.

EXLS. At about $39.58, EXLS trades near 25x trailing GAAP earnings but only about 15x forward EPS estimates, a gap that comes from adjusted and forecast earnings running well ahead of reported GAAP profit. The forward multiple is modest for a company growing revenue in the mid-teens, which is part of why analysts carry a mean target near $45. Q3 results on October 27, 2026 (consensus ~$0.56 EPS, ~$615M revenue) will show whether growth holds above 15%.

G. Genpact trades at roughly ~1.2x trailing revenue and about 8x forward earnings as of October 2026, near the bottom of the IT and business-services group, even after a ~23% three-month rebound. That gap exists because investors are discounting the durability of headcount-linked outsourcing revenue in an AI environment, not because current results are weak: Genpact has beaten EPS estimates in each of the last four quarters, and third-quarter results on November 5, 2026 carry a consensus near ~$1.04 of EPS, in line with company guidance of roughly ~$1.04 to ~$1.05. The valuation debate is about terminal demand rather than near-term execution.

Headline figures (approximate, October 2026): EXLS shows revenue (ttm) ~$2.24B, q2 2026 revenue ~$595M (+~15.6% YoY), margins (gross / operating / net) ~38.5% / ~14.6% / ~11.2%, net income (ttm) ~$250M; G shows revenue (ttm) ~$5.25B; Q2 2026 ~$1.34B, up ~7.1% year over year, q2 2026 adjusted eps ~$1.00 vs ~$0.97 consensus, up ~13.6%, margins (ttm) Gross ~36.5%, operating ~15.0%, net ~11.1%, net income (ttm) ~$583M; free cash flow ~$479M.

EXLS and G are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined EXLS and G exposure against your real portfolio. It is not an investment adviser.